HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Vivien Jiang Selected Research

MDX-1097

5/2015MDX-1097 induces antibody-dependent cellular cytotoxicity against kappa multiple myeloma cells and its activity is augmented by lenalidomide.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Vivien Jiang Research Topics

Disease

1Multiple Myeloma
05/2015

Drug/Important Bio-Agent (IBA)

1MDX-1097IBA
05/2015
1Lenalidomide (CC 5013)FDA Link
05/2015